Jeyakumar Meyyappan

#nephjc
Jeyakumar from India
Lurking today.
Interesting study to discuss.

#nephjc

Jeyakumar from Lucknow , India
No COI

Yeah, a shot in the dark — more for peace of mind than outcome #nephjc

We see this quite often here. We treat it like AAV, but honestly, the prognosis is almost always poor. The treatment is more out of hope than actual evidence.#Nephjc

15 Indian centres participated in the VISIONARY . There is increasing representation in the recent IgA trials.
#NephJC

Title slide

Ongoing late posts from @theisn.org #ISNWCN

from the high impact trial session - this was a great study design

The India ALLIANCE GRACE IgAN trial

Lead by Succeena Alexander from CMC Vellore

#NephSky
1/

Yes . We participated in the sibeprelinimab and iptacopan in igA trials.
Feasibility assessment ongoing for two more.
#nephjc

First things first — where the story starts!

Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC

Jeyakumar from India
No COI
#Nephjc

2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy

The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky

✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social

www.nephjc.com/news/igan-kd...

Well said , in era of raasi and flozins - no place for low protein diet . Vlpd is out of question #nephjc

#nephjc
Jeyakumar from India
I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review

#nephjc

Protein supplementation in CKD: The Visual Abstract — NephJC We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?

Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR?

www.nephjc.com/news/2025/10...

Thanks Marc.
Was easier when it had to follow a great guidelines summary from you guys.

📢 The 2025 ACC/AHA Hypertension Guideline Update is here.
Join the discussion on #Bluesky tonight (9/16, 9 pm EST).
We’ll unpack key changes, clinical implications, and what it means for your practice.
🫀🫘🧠
#Nephjc

ISPD APCN Malaysia 2025 . Talk on fungal peritonitis in CAPD

NephJC Shorts: MCD and FSGS Outcomes — NephJC A NephJC Shorts discussion of the long term data on kidney failure in FSGS and MCD

🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky

@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts

*the original article from @asnpublications.bsky.social

www.nephjc.com/news/nephjc-...

Thank you #nephjc and @kidneyboy.bsky.social .
TB deserved this one hour.
In India , any fever of more than 2 weeks duration is tuberculosis until you prove it otherwise .
And this book was a must read for me !

another great quote in that chapter

"Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also,
"And I don't deserve it, so I don't need to worry about it happening to me."

Stop blaming people for having a disease #NephJC"

#nephjc
Green best described Henry when he says “ Henry fit all the ideals of the consumptive - the wide eyes , the visible cheekbones , and the creative temperament “ . He wrote beautiful poems and his interest in writing blossomed during illness.

#nephjc
Jeyakumar Meyyappan from India
“Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “

“Where are the drugs? The drugs are where the disease is not. And where is the disease? The disease is where the drugs are not.”

A powerful book! Looking forward to tomorrow’s book club!

Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC

The HiLo Trial - Visual Abstract — NephJC Is a lower versus higher phosphate target beneficial to patients undergoing hemodialysis? Check out this crisp VA by Dr Sejal Lakhani

😎Check out the VA for HiLO by @sejalplakhani.bsky.social
🆒 This should be quite the discussion, don't miss it!
#NephJC #NephSky
www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract

High or Low Phosphate? Are we Missing the (P)oint? — NephJC This week, we will discuss the phosphate targets in dialysis. Are you aiming for HIgh or Low?

HiLo, HiLo it's off to work we go! ⛏️
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...

Severe AKI in the ICU: Management ca. 2025
#Nephpearls #AKIinICU #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/

#nephjc
Hello all ,
Jeyakumar from India .
I stick to creatinine for most decisions.
Would love to know about the gap though

Great job Marc @msocomd.bsky.social . :) #NephJC

Agree. The trial meant to see if starting agents upfront can make adifference. The point is these patients anyway wud have started the other pillars in sequence if made available. UACR (already < 1 gram ) & its reduction by 52% not strong point to start 2gether. Can still go in sequence #NephJC